Rebecca A. Gladdy

The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice.

ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes.

Plk4 is required for cytokinesis and maintenance of chromosomal stability.

Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene delivery.

Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation.

PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.

Toward Observation as First-line Management in Abdominal Desmoid Tumors.

Presacral Myelolipoma: Diagnosis on Imaging With Pathologic and Clinical Correlation.

Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment.

Retroperitoneal Sarcoma: Fact, Opinion, and Controversy.

Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges.

Prognostic models for RPS patients-Attempting to predict patient outcomes.

Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.

Risk-stratified surveillance in dermatofibrosarcoma protuberans: Less is more.

Comparison of published risk models for prediction of outcome in patients with extrameningeal solitary fibrous tumour.

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.

Early and Late Complications of Percutaneous Core Needle Biopsy of Retroperitoneal Tumors at Two Tertiary Sarcoma Centers.

If Active Surveillance is the Standard of Care for Desmoid Patients, When Should Intervention be Considered?

Virtual Biobanking for Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Initiative.

Abdominal neoplastic manifestations of neurofibromatosis type 1.

Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.

Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years.

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.

Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.

ASO Author Reflections: Rethinking Radiation Associated Angiosarcoma of the Breast-Secondary Malignancies That Require Expert Care for Improved Outcomes.

Multidisciplinary Intervention in Radiation-Associated Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment.

Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms.

Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma.

Correction to: Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma.

Leiomyosarcoma: Current Clinical Management and Future Horizons.

Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.

Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.

Evidence for the Current Management of Soft-tissue Sarcoma and Gastrointestinal Stromal Tumors and Emerging Directions.